Novo Nordisk's pricing tactics during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of rate gouging, declaring the stark distinction amongst U.S. price ranges and those in Europe and copyright. Rybelsus and copyright triggered t